InfuSystems HoldingsINFU +11.05%86 Days Payable is 66.65 as of Mar. 2026, which is 2% above its 10-year median of 65.29. GuruFocus rates INFU with a GF Score™ of 86/100 and a GF Value™ of $9.44 (Fairly Valued). The stock has 3 warning signs investors should review. Among 796 Medical Devices & Instruments companies, InfuSystems Holdings ranks worse than 61.31% on this metric.
The historical rank and industry rank for InfuSystems Holdings's Days Payable or its related term are showing as below:
INFU'
s Days Payable Range Over the Past 10 Years
Min: 47.61 Med: 65.29 Max: 84.32
Current: 57.08
During the past 13 years, InfuSystems Holdings's highest Days Payable was 84.32. The lowest was 47.61. And the median was 65.29.
INFU's Days Payable is ranked worse than 61.31% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.14
vs INFU: 57.08
InfuSystems Holdings's Days Payable
increased
from Mar. 2025 (53.45) to Mar. 2026 (66.65).
It may suggest that InfuSystems Holdingsdelayed paying its suppliers.
InfuSystems Holdings Days Payable Related Terms
InfuSystems Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for InfuSystems Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, InfuSystems Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InfuSystems Holdings Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where InfuSystems Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
InfuSystems Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InfuSystems Holdings (INFU) has a Days Payable of 66.65 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on InfuSystems Holdings and its competitors. This is near median its historical median of 65.29. Over the past decade, InfuSystems Holdings' Days Payable has ranged from 47.61 to 84.32. According to the industry distribution chart, InfuSystems Holdings ranks #488 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 61.3%.
Is InfuSystems Holdings' Days Payable too high?
InfuSystems Holdings' current Days Payable of 66.65 is near median its 10-year median of 65.29. Over the past 10 years, this metric has ranged from a low of 47.61 to a high of 84.32. The Medical Devices & Instruments industry median Days Payable is 68.14. InfuSystems Holdings' value of 66.65 is 2.2% below this industry median. Based on the distribution chart, InfuSystems Holdings ranks #488 out of 796 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, InfuSystems Holdings has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does InfuSystems Holdings' Days Payable compare to QTRX and LUCD?
According to the Medical Devices & Instruments industry distribution chart, InfuSystems Holdings ranks #488 out of 796 companies for Days Payable. This places InfuSystems Holdings in the lower half of its industry. The industry median Days Payable is 68.14. InfuSystems Holdings' value of 66.65 is 2.2% below this benchmark. Historically, InfuSystems Holdings' own Days Payable has ranged from 47.61 to 84.32 over the past decade. While the company's 10-year median is 65.29 vs. the industry median of 68.14, InfuSystems Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.14, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InfuSystems Holdings's current Days Payable of 66.65 is 2.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on InfuSystems Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InfuSystems Holdings's current Days Payable is 66.65, which is near median its own 10-year median of 65.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InfuSystems Holdings stock overvalued right now?
Based on GuruFocus' analysis, InfuSystems Holdings (INFU) is currently considered Fairly Valued. The stock's GF Value™ is $9.44, compared to a current price of $10.05 — trading 6.5% above its estimated fair value. The current Days Payable is 66.65, which is near median its 10-year median of 65.29 and 2.2% below the Medical Devices & Instruments industry median of 68.14. InfuSystems Holdings' overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For InfuSystems Holdings (INFU), the current Days Payable is 66.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InfuSystems Holdings (INFU) Overvalued in 2026?
Based on GuruFocus' analysis, InfuSystems Holdings stock appears to be overvalued.
The current stock price of $10.05 is trading 6.5% above its estimated GF Value™ of $9.44.
GuruFocus considers InfuSystems Holdings to be Fairly Valued.
Key valuation signals for INFU:
Days Payable: 66.65 (near median its 10-year median of 65.29)
GF Value™: $9.44 vs. price of $10.05 (6.5% above fair value)
Industry Position: 2.2% below the Medical Devices & Instruments median (#488 of 796)
No single metric tells the full story. See the INFU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
86GF Score
Get the complete analysis for INFU
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INFU has been successfully added to your 
